| ? |
B6-Lta/Tnftm1Fda/Orl
|
|
|
mutant strain
|
EM
|
17
|
Lta/Tnftm1Fda
|
targeted mutation 1, Francois Dautry
|
lymphotoxin A
|
targeted mutation
|
| + |
B6.129-Lta/Tnftm1Fda/Orl
|
B6.129/Sv-Lta/Tnftm1Fda/Orl, LT-a TNF-a
|
|
mutant strain
|
EM
|
17
|
Lta/Tnftm1Fda
|
targeted mutation 1, Francois Dautry
|
lymphotoxin A
|
targeted mutation
|
| + |
B6.129P2-Ltb/Tnf/Ltatm1Dvk/J
|
|
|
congenic strain, mutant strain
|
JAX
|
17
|
Ltb/Tnf/Ltatm1Dvk
|
targeted mutation 1, Dmitry V Kuprash
|
lymphotoxin A
|
targeted mutation
|
| 17
|
Ltb/Tnf/Ltatm1Dvk
|
targeted mutation 1, Dmitry V Kuprash
|
lymphotoxin B
|
targeted mutation
|
| 17
|
Ltb/Tnf/Ltatm1Dvk
|
targeted mutation 1, Dmitry V Kuprash
|
tumor necrosis factor
|
targeted mutation
|
| + |
B6.129S2-Ltatm1Dch/J
|
|
|
congenic strain, mutant strain
|
JAX
|
17
|
Ltatm1Dch
|
targeted mutation 1, David D Chaplin
|
lymphotoxin A
|
targeted mutation
|
| + |
B6;129S2-Ltatm1Dch/J
|
|
|
mutant stock
|
JAX
|
17
|
Ltatm1Dch
|
targeted mutation 1, David D Chaplin
|
lymphotoxin A
|
targeted mutation
|
| + |
C57BL/6J-Ltahlb382/J
|
C57BL/6J-hlb382/J, C57BL/6J-Ltahlb382, HLB-382, HLB382
|
|
coisogenic strain
|
JAX
|
17
|
Ltahlb382
|
heart, lung and blood 382
|
lymphotoxin A
|
chemically induced mutation
|
| ? |
Ltatm1(KOMP)Vlcg
|
|
|
mutant strain
|
KOMP
|
17
|
Ltatm1(KOMP)Vlcg
|
|
lymphotoxin A
|
targeted mutation
|